Rapivab
- Product NDC
- 72769-181
- 11-digit product format
- 727690181
- Labeler code
- 72769
- Product ID
- 72769-181_21ecf2ba-0923-48bc-b8ca-53f7d8cff24d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- peramivir
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Labeler
- BioCryst Pharmaceuticals, Inc.
- Application
- NDA206426
- Marketing category
- NDA
- Marketing start
- 2014-12-20
- Substance
- PERAMIVIR
- Active strength
- 600 mg/60mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rapivab
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PERAMIVIR | 600 mg/60mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | QW7Y7ZR15U |
| Rxcui | 876203, 1598082 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72769-181-01 | Rapivab | 20 mL in 1 VIAL, GLASS | SOLUTION | 20 | | 5 |
| 72769-181-03 | Rapivab | 3 in 1 CARTON | SOLUTION | 3 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72769-181 | RAPIVAB (PERAMIVIR) SOLUTION [BIOCRYST PHARMACEUTICALS, INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20240621_fe04f6cd-e71c-4bd4-abac-97720bba2a0d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72769-181-01 | 72769018101 | 20 mL in 1 VIAL, GLASS | 20 ml | | | | | Historical |
| 72769-181-03 | 72769018103 | 3 VIAL, GLASS in 1 CARTON (72769-181-03) / 20 mL in 1 VIAL, GLASS (72769-181-01) | | 2014-12-20 | 0000-00-00 | No | No | Current |